Thursday, February 20, 2014
Spurred by emerging evidence of biological overlaps between
Parkinson's disease and Alzheimer's disease, The Michael J. Fox Foundation for Parkinson's Research,
the Alzheimer's Association
and The W. Garfield
Weston Foundation have launched a grant program to
jump-start cross-disease research. The partners are soliciting project
proposals and expect to announce awards in July.
Getting the BAND together
BAND projects must use existing data or
biological samples from two large-scale clinical studies-the Parkinson's
Progression Markers Initiative (PPMI) and the Alzheimer's Disease Neuroimaging
The guidelines for BAND highlight
several areas on which funded projects could focus-such as analyzing cross-talk
between PD and AD markers and investigating common mechanisms across PD, AD and
other neurodegenerative diseases. However, Snyder and Sherer said that these
are just suggestions and do not reflect the partners' expectations or
priorities for funded projects.
Haas, M.J. SciBX 7(7);
Published online Feb. 20, 2014
1. Haas, M.J. SciBX
2. Haas, M.J. SciBX
3. Weiner, M.W. et al.
Alzheimers Dement. 9, e111-e194;
published online Aug. 7, 2013; doi:10.1016/j.jalz.2013.05.1769
4. Kang, J.-H. et al.
JAMA Neurol. 70, 1277-1287 (2013)
AND INSTITUTIONS MENTIONED
Alzheimer's Association, Chicago, Ill.
European Federation of Pharmaceutical Industries and
Foundation for the National Institutes of Health, Bethesda, Md.
Innovative Medicines Initiative, Brussels, Belgium
The Michael J. Fox Foundation for Parkinson's Research,
New York, N.Y.
The W. Garfield Weston Foundation, Toronto, Ontario, Canada
New Haven, Conn.